191. Werner syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
Werner syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 191 | Werner syndrome | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.000 |
| 193 | Prader-Willi syndrome | 1.000 |
| 299 | Cystic fibrosis | 1.000 |
| 2 | Amyotrophic lateral sclerosis | 1.000 |
| 75 | Cushing disease | 1.000 |
| 19 | Lysosomal storage disease | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 65 | Primary immunodeficiency | 1.000 |
| 96 | Crohn disease | 1.000 |
| 113 | Muscular dystrophy | 1.000 |
| 78 | Hypopituitarism | 1.000 |
| 168 | Ehlers-Danlos syndrome | 1.000 |
| 265 | Lipodystrophy | 1.000 |
| 74 | Prolactin secreting pituitary adenoma | 1.000 |
| 276 | Achondroplasia | 1.000 |
| 107 | Juvenile idiopathic arthritis | 1.000 |
| 3 | Spinal muscular atrophy | 1.000 |
| 274 | Osteogenesis Imperfecta | 1.000 |
| 236 | Pseudohypoparathyroidism | 1.000 |
| 187 | Kabuki syndrome | 1.000 |
| 195 | Noonan syndrome | 1.000 |
| 76 | Pituitary gonadotropin secretion hyperthyroidism | 1.000 |
| 238 | Vitamin D-resistant rickets | 1.000 |